Click here to access full prescribing information for Methylphenidate Hydrochloride Extended-Release Tablets, USP
Mallinckrodt’s Position on Safe and Effective Use of Opioids
For more than 140 years, the name Mallinckrodt has been synonymous with purity and innovation in the field of chemical manufacturing and medical products worldwide. Now a billion-dollar, global business and one of the fastest-growing pharmaceutical entities in the United States, Covidien's Mallinckrodt brand combines substantial knowledge in pharmaceutical ingredients and products with a strong heritage of manufacturing quality.
This information is intended for the use of our customers, patients and healthcare professionals in the United States only. Covidien recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside the United States.